View in EDS HTML Full Text PDF Full Text

Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.

Saved in:
Bibliographic Details
Title: Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
Authors: Tang R; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.; College of Pharmacy, Taizhou University, Taizhou, China., Ye H; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Chen G; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Dong X; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Li Z; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Lin F; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Huang T; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Qiu L; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Lin G; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Wu M; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China., Yu H; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Zou J; Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. zoujh-93@nus.edu.sg., Liu X; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China. xiaoloong.liu@gmail.com.; The Liver Disease Research Center of Fujian Province, Fuzhou, China. xiaoloong.liu@gmail.com., Cai Z; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China. caizhixiong1985@163.com.; The Liver Disease Research Center of Fujian Province, Fuzhou, China. caizhixiong1985@163.com.
Source: EMBO molecular medicine [EMBO Mol Med] 2026 Jun; Vol. 18 (6), pp. 2098-2123. Date of Electronic Publication: 2026 Apr 17.
Publication Type: Journal Article
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41998137
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tang+R%22">Tang R</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.; College of Pharmacy, Taizhou University, Taizhou, China.<br /><searchLink fieldCode="AU" term="%22Ye+H%22">Ye H</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+G%22">Chen G</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Dong+X%22">Dong X</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Lin+F%22">Lin F</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Huang+T%22">Huang T</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Qiu+L%22">Qiu L</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Lin+G%22">Lin G</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Wu+M%22">Wu M</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.; The Liver Disease Research Center of Fujian Province, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zou+J%22">Zou J</searchLink>; Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. zoujh-93@nus.edu.sg.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China. xiaoloong.liu@gmail.com.; The Liver Disease Research Center of Fujian Province, Fuzhou, China. xiaoloong.liu@gmail.com.<br /><searchLink fieldCode="AU" term="%22Cai+Z%22">Cai Z</searchLink>; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province & Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China. caizhixiong1985@163.com.; The Liver Disease Research Center of Fujian Province, Fuzhou, China. caizhixiong1985@163.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2026 Jun; Vol. 18 (6), pp. 2098-2123. <i>Date of Electronic Publication: </i>2026 Apr 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41998137
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44321-026-00424-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2098
    Titles:
      – TitleFull: Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tang R
      – PersonEntity:
          Name:
            NameFull: Ye H
      – PersonEntity:
          Name:
            NameFull: Chen G
      – PersonEntity:
          Name:
            NameFull: Dong X
      – PersonEntity:
          Name:
            NameFull: Li Z
      – PersonEntity:
          Name:
            NameFull: Lin F
      – PersonEntity:
          Name:
            NameFull: Huang T
      – PersonEntity:
          Name:
            NameFull: Qiu L
      – PersonEntity:
          Name:
            NameFull: Lin G
      – PersonEntity:
          Name:
            NameFull: Wu M
      – PersonEntity:
          Name:
            NameFull: Yu H
      – PersonEntity:
          Name:
            NameFull: Zou J
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Cai Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1757-4684
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: EMBO molecular medicine
              Type: main
ResultId 1